Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Treatment Type

  2.3.2 Market Size By Tumor Type

  2.3.3 Market Size By Drug Class

  2.3.4 Market Size By End User

 2.3.5 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Treatment performance & therapeutic outcome metrics

4.1.1 Share (%) of demand by treatment type (surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, others).

4.1.2 Improvement (%) in treatment effectiveness, survival rates, and patient recovery outcomes.

4.1.3 Reduction (%) in tumor progression, recurrence rates, and treatment-related complications.

4.2 Tumor-specific treatment & diagnosis metrics

4.2.1 Share (%) of treatment demand by tumor type (glioblastoma, astrocytoma, medulloblastoma, meningioma, pituitary tumors, others).

4.2.2 Improvement (%) in diagnostic accuracy, personalized treatment planning, and disease management.

4.2.3 Reduction (%) in diagnostic delays and disease progression risks.

4.3 Drug class performance & therapeutic efficiency metrics

4.3.1 Share (%) of demand by drug class (alkylating agents, targeted therapy drugs, immunotherapy drugs, antimetabolites, others).

4.3.2 Improvement (%) in drug efficacy, precision targeting, and patient response rates.

4.3.3 Reduction (%) in adverse side effects and resistance to therapy.

4.4 End-user & distribution efficiency metrics

4.4.1 Share (%) of demand by end user (hospitals, specialty clinics, research centres) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies).

4.4.2 Improvement (%) in treatment accessibility, patient care coordination, and drug availability.

4.4.3 Growth (%) in adoption driven by advancements in oncology therapeutics and increasing brain tumor incidence.

5. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Treatment Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Surgery

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Radiation Therapy

 5.4 Chemotherapy

 5.5 Targeted Therapy

 5.6 Immunotherapy

 5.7 Others

6. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Tumor Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Glioblastoma

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Astrocytoma

 6.4 Medulloblastoma

 6.5 Meningioma

 6.6 Pituitary Tumors

 6.7 Others

7. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Drug Class, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Alkylating Agents

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Targeted Therapy Drugs

 7.4 Immunotherapy Drugs

 7.5 Antimetabolites

 7.6 Others

8. Brain Tumor Treatment Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Specialty Clinics

 8.4 Research Centres

9. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2022–2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospital Pharmacies

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 Retail Pharmacies

  9.4 Online Pharmacies

10. Brain Tumor Treatment Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022–2035

  10.2.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022–2035

  10.2.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022–2035

  10.2.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022–2035

  10.2.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

  10.2.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.3.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022–2035

 10.3.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.3.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022–2035

 10.3.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.3.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.4.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022–2035

 10.4.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.4.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022–2035

 10.4.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.4.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.5.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022–2035

 10.5.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.5.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022–2035

 10.5.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.5.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.6.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022–2035

 10.6.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.6.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022–2035

 10.6.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.6.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 Egypt

  10.6.7.5 South Africa

  10.6.7.6 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

 11.6.1 Novartis AG.

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 SWOT Analysis

11.6.2 Roche Holding AG (Genentech)

11.6.3 Pfizer Inc.

11.6.4 Bristol Myers Squibb Company

11.6.5 AstraZeneca plc

11.6.6 Merck & Co. Inc. (MSD)

11.6.7 Servier Pharmaceuticals

11.6.8 Novocure Ltd.

11.6.9 Karyopharm Therapeutics Inc.

11.6.10 Celldex Therapeutics Inc.

11.6.11 Northwest Biotherapeutics Inc.

11.6.12 DelMar Pharmaceuticals

11.6.13 Aivita Biomedical Inc.

11.6.14 Cellenkos Inc.

11.6.15 Imvax Inc.

11.6.16 Istari Oncology Inc.

11.6.17 Insightec Ltd.

11.6.18 Carthera SAS

11.6.19 Champions Oncology Inc.

11.6.20 Tyme Technologies Inc.

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures